Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Faster, Cleaner, Better.

Merrimack Pharmaceuticals Inc (MACK)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Balance Sheet for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	09-2016	06-2016	03-2016	12-2015	09-2015
Assets
Current Assets
Cash & Cash Equivalents	36,565	21,592	48,338	185,707	56,451
Marketable Securities	12,003	61,176	84,153	N/A	6,000
Receivables	22,170	19,325	15,637	6,483	2,051
Inventories	14,770	12,321	8,083	3,717	N/A
TOTAL	$89,617	$119,033	$160,681	$201,394	$70,921

Non-Current Assets
PPE Net	17,564	19,614	20,824	21,915	19,964
Intangibles	10,527	10,671	10,816	10,960	11,090
Other Non-Current Assets	701	701	611	611	709
TOTAL	$28,792	$30,986	$32,251	$33,486	$31,763

Total Assets	$118,409	$150,019	$192,932	$234,880	$102,684

Liabilities
Current Liabilities
Accounts payable and accrued liabilities	49,699	44,796	50,449	52,082	38,702
Other current liabilities	1,974	1,935	1,817	1,527	1,488
TOTAL	$88,283	$90,888	$97,363	$103,746	$95,262

Non-Current Liabilities
Long Term Debt	216,871	215,544	259,843	257,655	126,261
Deferred Revenues	36,610	44,157	45,097	50,137	55,072
Other Non-Current Liabilities	3,751	4,477	5,071	5,407	6,829
TOTAL	$256,908	$260,535	$312,766	$315,062	$148,568

Total Liabilities	$345,191	$351,423	$410,129	$418,808	$243,830

Shareholders' Equity
Shares Outstanding, K	12,962	12,924	12,773	11,606	11,557
Common Shares	1,294	1,290	1,164	1,159	1,151
Retained earnings	-921,523	-891,455	-840,705	-802,232	-754,407
Other shareholders' equity	-2	1	-14	0	0
TOTAL	$-226,782	$-201,404	$-217,197	$-183,928	$-141,146

Total Liabilities And Equity	$118,409	$150,019	$192,932	$234,880	$102,684